Patent details

EP2575785 Title: ORAL DOSAGE FORMS OF BENDAMUSTINE AND THERAPEUTIC USE THEREOF

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2575785
WO Application Number:
EP2011002763
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11727917.4
WO Publication Number:
WO2011151086
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
01/06/2011
Grant date:
26/10/2022
EP Publication Date:
10/04/2013
WO Publication Date:
08/12/2011
Claims Translations Received Date:
Claims Translation B1 Received Date:
03/01/2023
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
26/10/2022
EP B1 Publication Date:
26/10/2022
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
31/05/2031
Lapsed By Expiration Date:
Patent Validated Date:
07/01/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
26/10/2022
 
 

 

Name:
Pharma& Schweiz GmbH
Address:
Riedstrasse 1, 6330 Cham, Switzerland (CH)

Agent

Name:
drs. B. Taneja
From:
06/01/2023
Address:
Southern Cross Kluyverweg 2A (Radex Building), 2629 HT, Delft, Netherlands (NL)
To:

Inventor

1

Name:
PATZAK, Ulrich
Address:
2300 AH Leiden, Netherlands (NL)

2

Name:
OUATAS, Taoufik
Address:
2300 AH Leiden, Netherlands (NL)

Priority

1

Priority Patent Number:
10005762
Priority Date:
02/06/2010
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Patent Number:
11075046
Priority Date:
14/03/2011
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 9/48; A61K 9/14; A61K 31/4184; A61K 47/10; A61K 9/16; A61K 9/20; A61K 9/28; A61K 31/573; A61P 35/00; A61P 35/02;

Publication

Bulletin

1

Bulletin Heading:
EP3
Journal edition number:
02/23
Publication date:
11/01/2023
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

2

Bulletin Heading:
EP2
Journal edition number:
43/22
Publication date:
26/10/2022
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202243
Publication date:
26/10/2022
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/06/2025
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
19/06/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
Dennemeyer and Co
Filing date Document type Document Description Number of pages File Type
06/01/2023 Outgoing Correspondence Letter no formal defects 1 PDF /5/6/7/0/3/0800830765/docs/ep11727917.4_1_524585l271.pdf
03/01/2023 Claims First filed claims 3 PDF /5/6/7/0/3/0800830765/docs/ep11727917.4_0_claims20230106104926850.pdf
03/01/2023 Incoming Correspondence Paper Other 2 PDF /5/6/7/0/3/0800830765/docs/ep11727917.4_2_incomingcorrespondencepaper20230106104926914.pdf
03/01/2023 Drawings First filed drawings 4 PDF /5/6/7/0/3/0800830765/docs/ep11727917.4_3_drawings20230103184518898.pdf